MSD Sverige, also known as Merck Sharp & Dohme, is a pharmaceutical company operating in Sweden. It is a subsidiary of Merck & Co., Inc., a global healthcare company headquartered in Kenilworth, New Jersey, USA. MSD Sverige is involved in the research, development, manufacturing, and marketing of a wide range of prescription medicines and vaccines. The company focuses on various therapeutic areas, including oncology, infectious diseases, and vaccines, contributing to advancements in healthcare and treatment options.
The company plays a significant role in the Swedish healthcare landscape, collaborating with healthcare professionals and institutions to improve patient outcomes. MSD Sverige is committed to innovation in pharmaceuticals and invests in research and development to bring new therapies to market. The company adheres to regulatory standards and guidelines to ensure the safety and efficacy of its products. Through its operations, MSD Sverige aims to address unmet medical needs and enhance the quality of life for patients in Sweden and beyond.